 DUBLIN, Ireland, Sept. 23, 2021 GLOBE NEWSWIRE -- GH Research PLC NASDAQ: GHRS, a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today provided business updates and reported financial results for the second quarter ended June 30, 2021. 